Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MustGrow Biologics's ROE % for the quarter that ended in Jun. 2026 was 35.43%. MustGrow Biologics's PB Ratio for the quarter that ended in Jun. 2026 was 5.37.
MustGrow Biologics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2026 was 6.60%.
MustGrow Biologics ROE % Adjusted to Book Value Related Terms
MustGrow Biologics ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics ROE % Adjusted to Book Value Chart
MGROF vs CTVA, CF, MOS: ROE % Adjusted to Book Value Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics ROE % Adjusted to Book Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 6.60% mean?
MustGrow Biologics (MGROF) has a ROE % Adjusted to Book Value of 6.60% as of Jun. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' ROE % Adjusted to Book Value too high?
MustGrow Biologics' current ROE % Adjusted to Book Value is 6.60%. Overall, MustGrow Biologics has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' ROE % Adjusted to Book Value compare to CTVA and CF?
MustGrow Biologics' ROE % Adjusted to Book Value of 6.60% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Agriculture company?
A good ROE % Adjusted to Book Value depends on the Agriculture industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current ROE % Adjusted to Book Value is 6.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
Based on GuruFocus' analysis, MustGrow Biologics (MGROF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.59, compared to a current price of $0.30 — trading 49.1% below its estimated fair value. The current ROE % Adjusted to Book Value is 6.60%. MustGrow Biologics' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current ROE % Adjusted to Book Value is 6.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MustGrow Biologics (MGROF) Overvalued in 2026?
Based on GuruFocus' analysis, MustGrow Biologics stock appears to be undervalued.
The current stock price of $0.30 is trading 49.1% below its estimated GF Value™ of $0.59.
GuruFocus considers MustGrow Biologics to be Possible Value Trap.
Key valuation signals for MGROF:
ROE % Adjusted to Book Value: 6.60%
GF Value™: $0.59 vs. price of $0.30 (49.1% below fair value)
No single metric tells the full story. See the MGROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
27GF Score
Get the complete analysis for MGROF
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
